Home / Resource Library / Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study

Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study

Study examined patients and oncologists treatment preferences in CLL.